Dynavax Technologies Corp. (DVAX)

10.89
NASDAQ : Health Technology
Prev Close 11.37
Day Low/High 10.89 / 11.60
52 Wk Low/High 10.35 / 23.85
Avg Volume 945.90K
Exchange NASDAQ
Shares Outstanding 62.62M
Market Cap 711.94M
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Seeking Bargains on Last Week's Selloff

Seeking Bargains on Last Week's Selloff

These 5 stocks are a good value on this weakness.

Dynavax Technologies Is Now Oversold (DVAX)

Dynavax Technologies Is Now Oversold (DVAX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

First Week Of DVAX September 21st Options Trading

First Week Of DVAX September 21st Options Trading

Investors in Dynavax Technologies Corp saw new options become available this week, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX options chain for the new September 21st contracts and identified one put and one call contract of particular interest.

Dynavax Technologies Becomes Oversold (DVAX)

Dynavax Technologies Becomes Oversold (DVAX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Children's Place, Abiomed, Barrick Gold: 'Mad Money' Lightning Round

Children's Place, Abiomed, Barrick Gold: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Children's Place, Abiomed, Barrick Gold, Dynavax Technologies, Zebra Technologies, Chesapeake Energy.

Be Alert For Buying Opportunities: Cramer's 'Mad Money' Recap (Monday 7/16/18)

Be Alert For Buying Opportunities: Cramer's 'Mad Money' Recap (Monday 7/16/18)

Jim Cramer says this market is all about being opportunistic, about being willing to fight the tide.

Biotech Bargains: Two Cheap Small-Cap Stocks in an Exciting Sector

Biotech Bargains: Two Cheap Small-Cap Stocks in an Exciting Sector

I continue to see these names as bargains in the biotech and biopharma space.

Small Cap Biotech Bargains

Small Cap Biotech Bargains

Here are 2 small caps I continue to see as bargains in this space.

4 Names to Watch Ahead of This Year's Key Cancer-Research Conference

4 Names to Watch Ahead of This Year's Key Cancer-Research Conference

These names are moving up or down in a big way ahead of releasing drug-trial results.

4 Names to Watch Ahead of Cancer Conference

4 Names to Watch Ahead of Cancer Conference

American Society of Clinical Oncology will see presentations from dozens of companies.

4 Names to Buy in a Refreshed Biotech Space

4 Names to Buy in a Refreshed Biotech Space

After a strong week for the biotech sector, these names have potential catalysts to move shares.

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

3 Favorite Biotech Stocks for the Second Quarter

3 Favorite Biotech Stocks for the Second Quarter

Your questions are answered in our latest addition of the biotech mailbag.

Interesting DVAX Put And Call Options For May 18th

Interesting DVAX Put And Call Options For May 18th

Investors in Dynavax Technologies Corp saw new options become available this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX options chain for the new May 18th contracts and identified one put and one call contract of particular interest.

Twilio, Apache, Tellurian: 'Mad Money' Lightning Round

Twilio, Apache, Tellurian: 'Mad Money' Lightning Round

Jim Cramer spotlights Twilio, Apache, Tellurian, Atara Biotherapeutics, Amarin, Dynavax Technologies

This Bull Still Runs: Cramer's 'Mad Money' Recap (Friday 3/9/18)

This Bull Still Runs: Cramer's 'Mad Money' Recap (Friday 3/9/18)

Jim Cramer says this is a market that triumphs over the gloom by simply taking stock of the good and running with it. He's got your game plan for next week.

Noteworthy Thursday Option Activity: DVAX, LVS, CVNA

Noteworthy Thursday Option Activity: DVAX, LVS, CVNA

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Dynavax Technologies Corp , where a total volume of 8,938 contracts has been traded thus far today, a contract volume which is representative of approximately 893,800 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 76.2% of DVAX's average daily trading volume over the past month, of 1.2 million shares.

Stanley A. Plotkin, M.D. Steps Down From Board Of Dynavax Technologies

Stanley A. Plotkin, M.D. Steps Down From Board Of Dynavax Technologies

Dr. Plotkin Will Continue as Scientific Advisor

First Week of October 19th Options Trading For Dynavax Technologies (DVAX)

First Week of October 19th Options Trading For Dynavax Technologies (DVAX)

Investors in Dynavax Technologies Corp saw new options become available this week, for the October 19th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Dynavax's HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] Recommended By CDC Advisory Committee On Immunization Practices For The Prevention Of Hepatitis B In Adults

Dynavax's HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] Recommended By CDC Advisory Committee On Immunization Practices For The Prevention Of Hepatitis B In Adults

HEPLISAV-B is the First and Only Two-Dose Vaccine in the U.S. for Hepatitis B Prevention in Adults

TheStreet Quant Rating: D- (Sell)